Researchers at Mount Sinai have developed an algorithm that can quickly detect COVID-19 based on how lungs appear in CT scans along with patient data such as age, sex, symptoms, bloodwork and potential contact with the virus. The algorithm imitates the workflow physicians use to diagnose COVID-19 and delivers a positive or negative diagnosis.
Mount Sinai researchers conducted scans of more than 900 patients received from institutional collaborators at Chinese hospitals between Jan.17 and March 3. The study’s results suggested that the AI algorithm can analyze large amounts of data much faster than traditional methods, which carries a significant impact during the pandemic.
Read the full news release here.
More articles on artificial intelligence:
Mayo Clinic tests AI to map how coronavirus affects heart health
7 ways hospitals use robots during the pandemic
Elon Musk claims AI chip could ‘fix anything that’s wrong with the brain’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
